New Study Finds a Protein Combination (Soy, Whey, Casein) is Best to Consume Post-Workout for Building MuscleApril 24, 2012
"This study confirms that consuming a blend of proteins (soy, whey and casein) versus whey protein alone provides a prolonged delivery of amino acids to the muscles, making it optimal for consumption following resistance exercise," said Dr. Rasmussen, professor and interim chair of the Department of Nutrition & Metabolism at the University of Texas Medical Branch and the senior author of this study. "The results of this study are critical for sports nutrition consumers and regularly active individuals."
The protein in the blend used in this study consisted of 25 percent isolated soy protein, 25 percent isolated whey protein and 50 percent casein. This combination of protein blends was determined in a preclinical study, of which was presented at Experimental Biology 2011.
Soy, whey and casein proteins are all absorbed at different rates during digestion. Whey protein is referred to as a "fast" protein because it is rapidly absorbed whereas casein, a "slow" protein, requires several hours to be digested. The ability of soy protein to deliver amino acids is "intermediate," meaning concentrations in blood peak somewhat later compared to whey, but its digestion rate is much quicker than casein. Hence, the effect of all three of these proteins combined appears to provide the extended release of amino acid delivery to the muscles.
"Your muscles don't recover in 30 minutes. It takes at least 24-48 hours for your muscles to recover after a resistance exercise," said Greg Paul, global marketing director for sports nutrition and weight management, Solae. "This study showed that protein blends can provide amino acid delivery for up to five hours, meaning if you consume a product or protein shake with these blends, the prolonged effect will deliver essential amino acids to feed your muscles until your next meal."
This was a double-blind, randomized clinical trial in nineteen young adults before and after ingestion of ~19 grams of protein from the blend or ~17.5 grams of whey protein (10 and 9, respectively, per group).
Additional detailed results from this study will be revealed at the upcoming American College of Sports Medicine annual meeting May 29-June 2 in San Francisco, Calif. This study used Solae™ SUPRO® isolated soy protein. For more information on this study, contact Dr. Rasmussen at firstname.lastname@example.org.
Solae, LLC is a world leader in developing soy-based ingredients for nutritious, great-tasting products. Solae provides solutions that deliver a unique combination of functional, nutritional, economical and sustainable benefits to our customers. Headquartered in St. Louis, Missouri, USA, the company was formed through a joint venture between DuPont (NYSE: DD) and Bunge (NYSE: BG) in 2003. Solae is a recipient of the 2011-2012 Ethisphere's Ethics Inside Certification and was recognized as one of the "World's Most Ethical Companies" in 2010, 2011 and 2012. For more information, visit www.Solae.com, or follow the company on Twitter at www.Twitter.com/SolaeLLC, Facebook at www.Facebook.com/SolaeLLC, and LinkedIn at www.linkedin.com/company/Solae-LLC.
Related Proteins Current Events and Proteins News Articles
New drug stalls estrogen receptor-positive cancer cell growth and shrinks tumors
An experimental drug rapidly shrinks most tumors in a mouse model of human breast cancer, researchers report in the Proceedings of the National Academy of Sciences.
Researchers develop new potential drug for rare leukemia
Researchers at the University of Michigan Comprehensive Cancer Center have developed a new drug that shows potential in laboratory studies against a rare type of acute leukemia.
Researchers discover bacterial genetic pathway involved in body odor production
For many, body odour is an unfortunate side effect of their daily lives. The smell is caused by bacteria on the skin breaking down naturally secreted molecules contained within sweat.
Panel predicts whether rare leukemia will respond to treatment
Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer than half of patients. Now, a new study identifies a panel of genetic markers that predicted which tumor samples would likely respond to treatment.
The CNIO identifies a new gene involved in hereditary neuroendocrine tumors
Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre (CNIO) -- led by Alberto Cascón and Mercedes Robledo -- have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component: pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively.
To stop cancer: Block its messages
The average living cell needs communication skills: It must transmit a constant stream of messages quickly and efficiently from its outer walls to the inner nucleus, where most of the day-to-day decisions are made.
Hidden costs: The unseen way organisms cope with climate change
Scientists have found a way to measure the unseen toll that environmental stress places on living creatures -- showing that they can rev up their metabolism to work more than twice as hard as normal to cope with change.
Biology in a twist -- deciphering the origins of cell behavior
Researchers at the Mechanobiology Institute (MBI) at the National University of Singapore have discovered that the inherent 'handedness' of molecular structures directs the behaviour of individual cells and confers them the ability to sense the difference between left and right.
How a deadly fungus evades the immune system
New research from the University of Toronto has scientists re-thinking how a lethal fungus grows and kills immune cells.
World first study reveals antibodies that may trigger psychosis in children
A world first study revealing the presence of two antibodies in a sub-group of children experiencing their first episode of psychosis affirms a longstanding recognition that auto-immune disorders play a significant role in psychiatric illness.
More Proteins Current Events and Proteins News Articles